Gluconic Acid

Gluconic Acid

SCHEMBL377417

CC(O)C(=O)[O-].CC(O)C(=O)[O-].O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Ca+2].[Mg+2]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.74
PDE4A P27815 1/20 0.55
USP2 O75604 1/20 0.42
SLCO1B1 Q9Y6L6 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 2/20 0.36
TP53 P04637 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gluconic Acid SCHEMBL303216 0.98 LMNA (0.77) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL5861529 0.98 LMNA (0.77) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL2266761 0.98 LMNA (0.77) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL21835970 0.98 LMNA (0.77) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL14662536 0.98 LMNA (0.77) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL22653996 0.96 LMNA (0.74) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL22653997 0.96 LMNA (0.74) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL4165311 0.96 LMNA (0.74) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL27096625 0.96 LMNA (0.74) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL27730141 0.94 LMNA (0.71) LMNAPDE4AUSP2SLCO1B1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408317-B1 DIETARY SUPPLEMENT GREENTEAM HOLDINGS LTD (GB) 2017-10-04 EP claimed
EP-2996495-A1 CALCIUM SUPPLEMENT Calinnova Ltd (GB) 2016-03-23 EP claimed
US-20150201650-A1 DIETARY SUPPLEMENT Greenteam Holdings Limited (GB) 2015-07-23 US claimed
WO-2014177876-A1 CALCIUM SUPPLEMENT CALINNOVA LTD (GB) 2014-11-06 WO claimed
US-20120121754-A1 Dietary Supplement CALLINOVA LTD (GB) 2012-05-17 US claimed
EP-2408317-A1 DIETARY SUPPLEMENT Calinnova Ltd (GB) 2012-01-25 EP claimed
WO-2010106351-A1 DIETARY SUPPLEMENT VETAFARM EUROPE LTD (GB) 2010-09-23 WO claimed
EP-2925757-B1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2017-10-04 EP disclosed
EP-2408317-B1 DIETARY SUPPLEMENT GREENTEAM HOLDINGS LTD (GB) 2017-10-04 EP disclosed
EP-2996495-A1 CALCIUM SUPPLEMENT Calinnova Ltd (GB) 2016-03-23 EP disclosed
US-20150201650-A1 DIETARY SUPPLEMENT Greenteam Holdings Limited (GB) 2015-07-23 US disclosed
CN-104351679-A Processing method of instant type carrot slices rich in zinc, calcium and magnesium UNIV ANHUI SCIENCE & TECH 2015-02-18 CN disclosed
WO-2014177876-A1 CALCIUM SUPPLEMENT CALINNOVA LTD (GB) 2014-11-06 WO disclosed
US-20120121754-A1 Dietary Supplement CALLINOVA LTD (GB) 2012-05-17 US disclosed
EP-2408317-A1 DIETARY SUPPLEMENT Calinnova Ltd (GB) 2012-01-25 EP disclosed
WO-2010106351-A1 DIETARY SUPPLEMENT VETAFARM EUROPE LTD (GB) 2010-09-23 WO disclosed